| HGNC Family | Non-coding RNAs |
| Name | microRNA 421 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐421 (miR-421) has emerged as a critical regulatory molecule that is frequently dysregulated in multiple human diseases. In several studies, miR-421 was found to modulate key DNA damage response and cell cycle checkpoint proteins—for example, it suppresses ATM expression, thereby altering the S‐phase checkpoint and increasing radiosensitivity, while its overexpression induced by oncogenic factors such as N‐Myc contributes to neuroblastoma tumorigenesis. In gastric cancer, altered miR-421 expression has been investigated for its potential biomarker value, and in pancreatic cancer it targets the tumor suppressor DPC4/Smad4, promoting proliferation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistic investigations have revealed that miR-421 directly targets several genes pivotal for the regulation of cell death, differentiation, and stress responses. It downregulates proteins such as ACE2, FXR, FOXO4, caspase-3, and PDCD4—thereby promoting oncogenic phenotypes like enhanced proliferation, migration, invasion, resistance to apoptosis, and chemoresistance in cancers including gastric, biliary tract, nasopharyngeal, and osteosarcoma. Moreover, by repressing regulators such as SERPINE1 and modulating apoptotic mediators in various tumor types, miR-421 exhibits a multifaceted role; its targeting of molecules like TMEM48 in lung cancer and caspase-10 in breast cancer further underscores its capacity to influence divergent cellular pathways."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its direct regulatory functions in tumor cells, miR-421 holds promise as a circulating biomarker and therapeutic target. In various malignancies—including gastric, prostate, and thyroid cancers—as well as in non-neoplastic conditions like metabolic syndrome and even in pigmentary disorders such as vitiligo, dysregulated expression of miR-421 correlates with disease progression, metastasis, and treatment resistance. Furthermore, miR-421 is subject to modulation by competing endogenous RNAs such as circular RNAs and long noncoding RNAs (e.g., circDHRS3, lncRNA SNHG1, and circ_C16orf62), which sponge miR-421 and thereby indirectly influence the expression of downstream targets. Intriguingly, while miR-421 often exhibits oncogenic properties, in certain contexts—such as in subsets of breast, lung, and cervical cancers—it can exert tumor-suppressive effects via targeting anti-apoptotic factors or oncogenes. Collectively, these findings underscore the complex, context-dependent roles of miR-421 in regulating cell proliferation, apoptosis, migration, inflammation, and chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Hailiang Hu, Liutao Du, Gindy Nagabayashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ATM is down-regulated by N-Myc-regulated microRNA-421."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0907763107"}], "href": "https://doi.org/10.1073/pnas.0907763107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20080624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20080624"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhen Jiang, Junming Guo, Bingxiu Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of miR-421 in human gastric carcinoma and its clinical association."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastroenterol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00535-009-0135-6"}], "href": "https://doi.org/10.1007/s00535-009-0135-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19802518"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19802518"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiaoxiao Ge, Xinyang Liu, Fengjuan Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8228"}], "href": "https://doi.org/10.18632/oncotarget.8228"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27016414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27016414"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jun Hao, Shuyu Zhang, Yingqi Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2011.02.086"}], "href": "https://doi.org/10.1016/j.bbrc.2011.02.086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21352803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21352803"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yu Li, Wei Li, Jian-Guo Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-1921-1"}], "href": "https://doi.org/10.1007/s13277-014-1921-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25012242"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25012242"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Daniel W Lambert, Louise A Lambert, Nicola E Clarke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Sci (Lond) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/CS20130420"}], "href": "https://doi.org/10.1042/CS20130420"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24564768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24564768"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiang-yu Zhong, Jian-hua Yu, Wei-guang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2011.11.028"}], "href": "https://doi.org/10.1016/j.gene.2011.11.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22146319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22146319"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yan Zhang, Wei Gong, Shuangshuang Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-11-0473"}], "href": "https://doi.org/10.1158/1541-7786.MCR-11-0473"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22446874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22446874"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Liang Chen, Yanping Tang, Jian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2013.05.056"}], "href": "https://doi.org/10.1016/j.bbrc.2013.05.056"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23707940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23707940"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jian-Hong Wu, Yong-Liang Yao, Tao Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian Pac J Cancer Prev (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7314/apjcp.2014.15.13.5463"}], "href": "https://doi.org/10.7314/apjcp.2014.15.13.5463"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25041019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25041019"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Alexandre Marchand, Carole Proust, Pierre-Emmanuel Morange, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-421 and miR-30c inhibit SERPINE 1 gene expression in human endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0044532"}], "href": "https://doi.org/10.1371/journal.pone.0044532"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22952991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22952991"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Shuguang Zhou, Bing Wang, Jun Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4578-5"}], "href": "https://doi.org/10.1007/s13277-015-4578-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26758431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26758431"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Qiong Wu, Hongjuan Wang, Lan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa_circ_0001546 acts as a miRNA-421 sponge to inhibit the chemoresistance of gastric cancer cells via ATM/Chk2/p53-dependent pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.10.117"}], "href": "https://doi.org/10.1016/j.bbrc.2019.10.117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31668372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31668372"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yongqin Pan, Genlong Jiao, Cunchuan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.08.058"}], "href": "https://doi.org/10.1016/j.biopha.2016.08.058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27583980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27583980"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yiwei Wang, Zipeng Liu, Jian Shen "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421-targeted PDCD4 regulates breast cancer cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2018.3932"}], "href": "https://doi.org/10.3892/ijmm.2018.3932"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30365117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30365117"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zhaozhou Ren, Ming He, Tao Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2019.1683331"}], "href": "https://doi.org/10.1080/15384047.2019.1683331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31718519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31718519"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sun Jingyue, Wang Xiao, Zha Juanmin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFAP2E methylation promotes 5‑fluorouracil resistance via exosomal miR‑106a‑5p and miR‑421 in gastric cancer MGC‑803 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2019.10237"}], "href": "https://doi.org/10.3892/mmr.2019.10237"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31115533"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31115533"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Haiyan Liu, Yongjian Gao, Defeng Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation between microRNA-421 expression level and prognosis of gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26823855"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26823855"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Bogusz Trojanowicz, Thomas Imdahl, Christof Ulrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nephron (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000493805"}], "href": "https://doi.org/10.1159/000493805"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30326474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30326474"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "T B Hu, H S Chen, M Q Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2018_170306N159"}], "href": "https://doi.org/10.4149/neo_2018_170306N159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29322788"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29322788"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Liang Xue, Dong Yang "}, {"type": "b", "children": [{"type": "t", "text": "MiR-421 inhibited proliferation and metastasis of colorectal cancer by targeting MTA1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J BUON (2018)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30610787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30610787"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Yu Jin Kim, Ki-Chul Hwang, Sang Woo Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.24061"}], "href": "https://doi.org/10.7150/ijms.24061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29725252"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29725252"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Feridun Akkafa, İsmail Koyuncu, Ebru Temiz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.06.023"}], "href": "https://doi.org/10.1016/j.bbrc.2018.06.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29906465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29906465"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xiaorong Wu, Jiale Zhou, Ling Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircCYP24A1 hampered malignant phenotype of renal cancer carcinoma through modulating CMTM-4 expression via sponging miR-421."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-022-04623-0"}], "href": "https://doi.org/10.1038/s41419-022-04623-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35220395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35220395"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Guodong Zhao, Liang Xu, Limei Hui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Level of circulated microRNA-421 in gastric carcinoma and related mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26823741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26823741"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Liuqing Yuan, Houren Xu, Rui Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ZFAS1 alleviates bupivacaine-induced neurotoxicity by regulating the miR-421/zinc finger protein564 (ZNF564) axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1960776"}], "href": "https://doi.org/10.1080/21655979.2021.1960776"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34414857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34414857"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ying-Nan Yang, Lu-Qin Bian, Xiao-Dong Ling, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421 promotes proliferation and invasion of non-small cell lung cancer cells through targeting PDCD4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2019.152555"}], "href": "https://doi.org/10.1016/j.prp.2019.152555"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31445715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31445715"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Jun Liu, Chaoyue Zhao, Song Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA SNHG1 promotes the development of oral cavity cancer via regulating the miR-421/HMGB2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Biol (Noisy-le-grand) (2020)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34174971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34174971"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "F Jiang, H-Y Zhou, L-F Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421 promotes inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis by targeting SPRY1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201910_19125"}], "href": "https://doi.org/10.26355/eurrev_201910_19125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31646548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31646548"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "X J Lai, X Y Cheng, L D Hu "}, {"type": "b", "children": [{"type": "t", "text": "microRNA 421 induces apoptosis of c-33a cervical cancer cells via down-regulation of Bcl-xL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Mol Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4238/gmr15048853"}], "href": "https://doi.org/10.4238/gmr15048853"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27886335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27886335"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Aécio A Braga, Raul H Bortolin, Magda E Graciano-Saldarriaga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenomics (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/epi-2020-0247"}], "href": "https://doi.org/10.2217/epi-2020-0247"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33678000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33678000"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Yanfeng Jin, Shanshan Zhang, Li Liu "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_C16orf62 Suppresses Cell Growth in Gastric Cancer by miR-421/Tubulin beta-2A Chain (TUBB2A) Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.924343"}], "href": "https://doi.org/10.12659/MSM.924343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33006960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33006960"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Anbing Dong, Jianhua Zhang, Wenhai Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of miR-421 predicts poor prognosis and promotes proliferation, migration, and invasion of papillary thyroid cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Chin Med Assoc (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/JCMA.0000000000000426"}], "href": "https://doi.org/10.1097/JCMA.0000000000000426"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32881717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32881717"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Xuecheng Sun, Tao Wang, Bo Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ΜicroRNA‑421 participates in vitiligo development through regulating human melanocyte survival by targeting receptor‑interacting serine/threonine kinase 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2019.10878"}], "href": "https://doi.org/10.3892/mmr.2019.10878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31974624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31974624"}]}]}]}
|
| Synonyms | MIRN421, HSA-MIR-421 |
| NCBI Gene ID | 693122 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR421 has 310 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 16 datasets.
Click the + buttons to view associations for MIR421 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR421 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR421 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR421 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR421 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR421 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR421 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR421 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR421 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR421 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR421 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR421 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR421 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR421 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR421 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR421 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| WikiPathways Pathways 2014 | pathways involving MIR421 protein from the Wikipathways Pathways 2014 dataset. | |